Hall Bulgaria

March 27, 2021   |   09:30 - 17:30 (Eastern European Time – Sofia, Bulgaria)

<> Topic: HEALTH TECHNOLOGY ASSESSMENT – STRATEGIES FOR ACCELERATED ACCESS

<> Summary: Approach to health technology assessment and access for innovative therapies are rapidly evolving in recent years. Each country across Europe has framed its own pathway, while payers continue struggling to ensure sustainable access for innovative treatments within limitations of their budgets. There is a growing interest to synergise HTA methods, optimise processes and criteria, including establishment of early dialogue, utilization of common decision-making tools, while respecting country-specific needs.

8th annual symposium “HEALTH TECHNOLOGY ASSESSMENT – STRATEGIES FOR ACCELERATED ACCESS”  will be a unique opportunity to network with stakeholders and learn from renowned international speakers with global, country-specific, academic and regulatory expertise in HTA, international reference pricing, negotiation of discounts and rebates and formulation of managed entry agreements.

<> Language: The symposium will be held in English.

<> Access: An invitation from the Organizing Committee is required to participate in the HTA symposium, and places are limited. Please contact: info@raredis.org

<> Organizer: Institute for Rare Diseases

<> Agenda:

09:30 - 09:40 Prof. Rumen Stefanov: Opening

09:40 - 10:10 Assoc. Prof. Georgi Iskrov: Economic modeling of cancer therapies - what is doable and what is meaningful?

10:15 - 11:00 Prof. Dan Greenberg: Can results of willingness-to-pay studies inform coverage and reimbursement decisions? The case of oncology

11:15 - 12:00 Mr. François Houÿez: How patients see the future cooperation on HTA in Europe - the case of orphan medicinal products

12:15 - 13:00 Prof. Katarzyna Kolasa: How digital transformation will change the access to treatment for patients with rare disease?

13:15 - 14:00 Break

14:15 - 15:00 Dr. Iñaki Ibarluzea: What the new HTA definition means in terms of value analysis and procurement models

15:15 - 16:00 Dr. Andras Incze: International reference pricing as a driver of managed-entry agreements

16:15 - 17:00 Prof. Jaime Espin: Impact of discounts and rebates on managed entry agreements and pharmaceutical expenditures

17:15 - 17:30 Prof. Rumen Stefanov: Closing of the symposium

Useful information:

The Virtual Congress Venue is designed to provide maximum functionality and convenience

for working with a desktop computer. If you prefer to use a mobile device (phone or tablet),

we recommend using it in landscape mode. For detailed information, please read here.

Check the system requirements for using the Virtual Congress Venue:

Check system requirements

Check the speed of your internet connection: www.fast.com

Set up a microphone and camcorder for online conferencing: https://zoom.us/test

If you have any questions or need help, please do not hesitate to contact us at

info@raredis.org or via the live chat icon with our support.